Controlled Release Microspheres pH Stabilization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing biodegradable microspheres for drug delivery, particularly for water-soluble drugs like peptides and proteins, face challenges in achieving uniform particle size, effective drug loading, and maintaining stability, leading to inefficient drug release and potential pH imbalances in the biological environment.
Innovation Solution
A controlled release system is developed using a water-in-oil-in-water double emulsion method, incorporating an alkaline material like hydroxyapatite to stabilize pH between 6.5 and 8.5, and achieving drug encapsulation rates exceeding 80%, with a slow release rate and reduced burst release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional emulsion solvent evaporation method is used, then microspheres can be prepared, but uniform particle size and effective drug loading are difficult to achieve
Solution Approach 1:
The preparation process is divided into two distinct emulsion stages: first forming w/o emulsion with controlled droplet size, then forming w/o/w double emulsion. This segmentation allows independent control of each emulsion step to achieve uniform particle size distribution that cannot be obtained through single-stage emulsification.
Solution Approach 2:
The patent employs a double emulsion structure where water droplets containing drug are nested within oil phase droplets, which are then nested within the external aqueous phase. This nested configuration (w/o/w) provides multiple protective layers and enables precise control of drug encapsulation while maintaining uniform microsphere size.
2Quantity of substance
If w/o/w double emulsion method is used for water-soluble drugs, then drug loading efficiency improves, but particle size becomes too small (<10 μm) for effective delivery
Solution Approach 1:
The patent systematically varies critical parameters including oil phase to aqueous phase volume ratios, surfactant concentrations, emulsion homogenization speeds and times, and crosslinking conditions. By optimizing these parameters, the method achieves both high drug loading efficiency (>80%) and clinically relevant microsphere sizes (10-500 μm) that can be delivered by conventional injection methods.
3Duration of action of moving object
If biodegradable polymers are used for sustained release, then drug release rate is controlled, but pH imbalance occurs in the biological environment
Solution Approach 1:
The patent introduces buffering agents (phosphates, carbonates, bicarbonates, citrates, or amino acids) as intermediary substances within the microsphere formulation. These buffers act as mediators that neutralize pH changes during polymer degradation and drug release, maintaining physiological pH (6.5-7.5) throughout the sustained release period while preserving drug stability and biological compatibility.
4Quantity of substance
If high drug loading is achieved, then pharmaceutical activity increases, but burst release increases causing side effects
Solution Approach 1:
The patent creates spatial heterogeneity in drug distribution within the microsphere structure through the double emulsion process. Drug is preferentially localized in the internal water phase droplets, while the oil phase and external aqueous phase provide controlled release barriers. This local quality differentiation enables high overall drug loading while preventing rapid burst release, as the drug must traverse multiple phases for release.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system effectively protects sensitive drugs, maintains a stable pH, and achieves high drug encapsulation and controlled release, ensuring prolonged drug activity and minimizing side effects.
Implementation Method 1
incorporating an alkaline material like hydroxyapatite to stabilize pH between 6.5 and 8.5
Implementation Method 2
A controlled release system is developed using a water-in-oil-in-water double emulsion method
Implementation Method 3
Mixing the first emulsion with a second aqueous solution to form a second emulsion containing delayed-release microsphere
Implementation Method 4
a hydrophobic polymer is dissolved in a water-immiscible organic solvent
Implementation Method 5
biodegradable polymers have been widely investigated as drug carriers
Data Source
AI summary
A controlled release system and manufacturing method is provided. The method comprises providing a first aqueous solution containing a hydrophilic drug and an alkaline agent, providing an organic solution containing a hydrophobic molecule, providing a second aqueous solution containing a hydrophilic surfactant, mixing the first hydrophilic solution with the organic solution to form a first emulsion, and mixing the first emulsion with a second aqueous solution to form a second emulsion containing delayed-release microsphere.